Home/Filings/4/0001209191-17-003704
4//SEC Filing

MATEON THERAPEUTICS INC 4

Accession 0001209191-17-003704

$OTLCCIK 0000908259operating

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 5:02 PM ET

Size

5.9 KB

Accession

0001209191-17-003704

Insider Transaction Report

Form 4
Period: 2017-01-12
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2017-01-12$0.38/sh+550,000$206,250550,000 total
    Exercise: $0.38Exp: 2027-01-12Common Stock (550,000 underlying)
Footnotes (2)
  • [F1]Dr. Schwieterman was awarded options to purchase Mateon Therapeutics, Inc. common stock, $0.01 par value per share, pursuant to the Mateon Therapeutics, Inc. 2017 Equity Incentive Plan in connection with his service as President and Chief Executive Officer.
  • [F2]The Options will vest in forty-eight equal monthly installments beginning one month after the grant date.

Issuer

MATEON THERAPEUTICS INC

CIK 0000908259

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000908259

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:02 PM ET
Size
5.9 KB